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Regional serum cholesterol differences
in Belgium: do genetically determined
cardiovascular risk factors contribute?
C Cobbaerta and P Mulderb
Background Differences in serum lipid distribution and mortality from ischaemic heart disease
have repeatedly been reported between Belgian northerners and southerners.
We investigated whether serum lipoprotein(a) (Lp(a)) and apolipoprotein (apo)
E polymorphism were involved.
Methods Fasting serum lipids, apo A-I and B, and Lp(a) levels were examined in randomly
selected, 20-39 year old Belgian males and females from the north (Flanders) and
the south (Wallonia) of Belgium (N = 900). Apo E phenotype distribution was
investigated in random subsamples from either region (N = 249).
Results Mean serum cholesterol, low density lipoprotein cholesterol (LDL-c), apo B and
triglyceride levels were higher in Walloons compared to Flemings within each
gender, the difference being significant in 30-39 year old males. Average high
density lipoprotein cholesterol and apo A-I levels were significantly lower in
30-39 year old male southerners, compared to their northern counterparts.
Median Lp(a) was 67 mg/1 in northerners and 75 mg/1 in southerners (NS). The
apo E phenotype distribution was similar in both regions (x2 = 7.213; d.f. = 5;
P = 0.2053), whereas the average effects of the apo E alleles differed between the
regions. In southerners the e4 effect upon adjusted apo B and LDL-c levels was
=+12% and the e2 effect was °-15%; in northerners the e4 and e2 effects were
•=+5% and =-25%, respectively. The apo E polymorphism did not affect serum
Lp(a) levels.
Conclusions Regional cholesterol differences between Flemings and Walloons cannot be
explained by differences in serum Lp(a) or apo E phenotype distribution. The less
favourable e2 and e4 effects in southerners compared to northerners reflect
modulation of the apo E gene by particular environments.
Keywords Lipoprotein(a) levels, apolipoprotein E polymorphism, Flemings, Walloons,
Belgium, cardiovascular risk factors
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Regional differences in serum lipid distribution and mortality
from ischaemic heart disease have repeatedly been described
for Belgium, a small industrialized country of only 11 781
square miles with the pecularity of two cultural communities,
i.e. a Dutch-speaking community in the north (Flanders and
Campine), and a French-speaking community in the south
(Wallonia). The linguistic difference has created a cultural
frontier, cutting horizontally through Belgium, hampering the
transmission of information from one side to the other, and
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leading to newspapers, radio and television addressing them-
selves separately to one or other community.
It was first discovered at the end of the 1960s, during an
epidemiological survey in the Belgian army, that important
regional serum cholesterol differences existed in males in all
5-year age classes between the age of 15 and 55 years.1 The
higher serum cholesterol in the southerners, coupled to a higher
morbidity from ischaemic heart disease and peripheral vascular
disease, was confirmed in the 1970s by surveys in male postal2
and factory workers.3 In the 1980s the Belgian Interuniversity
Research on Nutrition and Health (BERNH) documented similar
cholesterol differences between Flemings and Walloons in all
age categories, both in males and females, and found differences
of 20% in coronary mortality between the two regions.4 As to
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the origin of these serum cholesterol differences, the less favour-
able food pattern in Walloons in terms of saturated and poly-
unsaturated fat intake as well as nutritional cholesterol intake
have been held responsible.4 Whether, besides differences in
lifestyle factors, variations in genetically determined cardio-
vascular risk factors might contribute to the observed north-
south differences in serum cholesterol has not been investigated
so far. Two potential candidates, co-determining serum lipid
and serum cholesterol levels, that might be involved are the
type and blood levels of apolipoprotein (apo) E5"10 and lipopro-
tein(a) (Lp(a)).11-15
This investigation was undertaken to determine whether the
alleles governing apo E and apo(a) might contribute to regional
cholesterol differences in Belgium. To this end, apo E poly-
morphism and serum Lp(a) levels were examined in randomly
selected 20-39 year old males and females from either region,
in relation to serum lipid and apolipoprotein levels. Besides, it
was investigated whether apo E polymorphism affected serum
Lp(a) levels.
Methods
Population description and sample collection
Sera were obtained from healthy, unrelated, 20-39 year old
employees from Flanders (N = 683) and Wallonia (N = 217).
Hitherto, employees working at companies spread throughout
the two regions (32 companies in Flanders; 15 companies in
Wallonia) were, prior to a scheduled medical check-up, invited
to participate in this study. Previous selection and subsequent
invitation, and medical check-up were conducted by the
Flemish IDEWE and the Wallonian CeSI, two 'Centres de Ser-
vices Inter-enterprises-Medecine du Travail'. Informed consent
was obtained from all participants.
Blood was collected in the morning at the point of medical
check-up into whole blood tubes after overnight fasting
(including abstinence from alcohol). The same day, the whole
blood tubes were transported to the Central Laboratory of the
Leuven University Hospital, Belgium. No special precautions
were taken. Serum was harvested on the day of sample col-
lection by centrifugation at 1500 g for 10 min at room temper-
ature. Subsequently, the serum was divided into five aliquots:
(1) for determination of serum lipids and y-glutamyltransferase
activity (GGT); (2) for apo A-I and B analyses; (3) for Lp(a)
analyses; (4) for apo E phenotyping and (5) a left-over serum
aliquot for long-term storage at -70°C. Serum lipids and GGT
were determined freshly, whereas aliquots for apo A-I and B,
and Lp(a) analyses were stored frozen at -20°C for a maximum
of 2 months. Before freezing, aliquots for apo E phenotyping
(250 uJ) were preserved with an anti-proteolytic cocktail (5 u.1)
containing aprotinin (1 mg/ml), lima bean trypsin inhibitor
(2 mg/ml), soybean trypsin inhibitor (2 mg/ml), benzamidin
(3.132 mg/ml), glutathione (20 mg/ml), D-phenylalanyl-L-propyl-
L-arginine chloromethyl keton (50 |ig/ml), NaN3 (10 mg/ml),
Tritriplex (0.65 mg/ml), streptomycin sulfate (8 mg/ml), and
sodium benzylpenicillin (8 mg/ml).
Questionnaire
Questionnaires were distributed at the time of the medical
check-up. Participants were invited to fill in their identity, home
address and postcode, nationality, ethnicity (Caucasian/Asian/
African), date of birth, type of education, profession and age at
graduation. Moreover, participants were questioned about the
current use (and type) of hormonal contraceptives and possible
pregnancies or hysterectomies (for females), about smoking,
drinking, and sporting habits, and about the use of lipid-lowering
medication. Hitherto, the number and type of alcoholic bever-
ages (wine, beer, liqueur) drunk per day and per week were
scored, as well as the number of cigarettes, cigars or pipes
smoked per day, and the hours of physical exercise taken per
week.
The filled-in questionnaires were checked for completeness
by the physicians who conducted the medical check-up. Additional
questions were raised whenever appropriate. Non-Caucasians,
pregnant and hysterectomized women, and individuals taking
any lipid-lowering medication were excluded from the study at
this stage.
Socioeconomic status
Socioeconomic status was essentially scored as described by
Black,16 by means of six categories that are primarily based on
occupation: three non-manual higher categories (classes I, II,
IIIN; categorized as 1, 2, and 3 respectively) and three manual
lower categories (IIIM, IV, V; categorized as 4, 5, and 6 respect-
ively). For classification, type of education and age at gradua-
tion were also taken into account. Scoring was done by two
independent observers, who were blinded to all study results.
Inconsistent scores were verified; in case of remaining disagree-
ment definitive categorization was done by a third observer.
Anthropometric and blood pressure measurements
Body height was measured to the nearest 0.5 cm. Body weight
was measured to the nearest 0.1 kg. Body mass index (BMI)
was calculated as weight (kg) divided by height (m2). Systolic
(SBP) and diastolic (DBP) blood pressure were measured to the
nearest mmHg. All measurements were performed by the
physicians in charge of the medical check-up.
Serum GGT, serum lipid and apolipoprotein analyses
Cholesterol was determined enzymatically, using CHOD-PAP
reagent. High density and low density cholesterol (HDL-c, LDL-c)
were determined with CHOD-PAP reagents, after precipitation
with MgCl2/phosphotungstic acid and polyvinyl sulphate, re-
spectively. Besides, LDL-c was estimated by the original Friede-
wald formula,17 as well as by a modified Friedewald formula
that corrects for the Lp(a)-cholesterol contribution.6 Total trigly-
cerides were determined using a GPO-PAP reagent; no free glycerol
correction was made. Apolipoprotein A-I and B were deter-
mined by immunoturbidimetry (reference values: 0.80-1.50 g/1
for apo A-I and 0.60-0.95 g/1 for apo B). y-Glutamyltransferase
(GGT) activity was determined using y-glutamyl-carboxynitro-
anilide and glycylglycine substrates (reference values: 5-28 IU/1
in males; 4-18 IU/1 in females). All reagents were purchased
from Boehringer (Boehringer Mannheim, Mannheim,
Germany).
Accuracy of the routine cholesterol and HDL-c assay methods
used was checked retrospectively by the Lipid Reference
Laboratory of the University Hospital, Rotterdam, the Nether-
lands, versus the Abell-Kendall Reference Method and the CDC
HDL-c Designated Comparison Method, respectively.18'19
Throughout the study period (i.e. at five checkpoints) average
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biases of all six samples analysed per checkpoint were ^ 3 % for
total cholesterol and * 5 % for HDL-c, fulfilling the recommended
1998 NCEP performance guidelines for these analytes.18 '19
Serum lipoprotein(a) quantification and
apo E phenotyping
Iipoprotein(a) was determined using an anti-apo(a) polydonal
capture ELJSA from Biopool (TintElize lipoprotein(a). Cat. No.
610220; Biopool AB, Ume3, Sweden).20 Apo E phenotyping
was performed by a micro-method based on isoelectric focusing
(pH 4-7) of delipidated serum samples, followed by immuno-
blotting on a nitrocellulose filter and use of polyclonal rabbit
anti-apo E antiserum as the first antibody.21 Serum lipopro-
tein(a) mass measurements were performed in all volunteers
(N = 900), whereas apo E phenotyping was done in a subgroup
(N = 249) of Flemings (N = 125) and Walloons (N = 124).
After laboratory analysis, lipid and lipoprotein data were
reported by letter to each participant, together with reference
and/or consensus values of the investigated parameters and an
interpretation of the lipid profile (normal/abnormal).
Statistical analysis
Regional differences between baseline characteristics and serum
lipid and (apo)lipoprotein data were determined with Students'
T-test, Mann-Whitney rank-sum test, or x2 test where appro-
priate. The Lp(a) data were logarithmically transformed (natural
logarithm), due to extreme skewness of its distribution.
Multiple linear regression models controlling for a number of
covariables (ANCOVA) were used for examining the differences
in serum lipid and (apo)lipoprotein levels between Flanders and
Wallonia. To this end, cholesterol, LDL-c, apo B and Lp(a) data
were logarithmically transformed, whereas this was not
required for HDL-c and apo A-I. A first model controlled for the
covariables age, sex and BMI. A second model controlled for
age, sex, BMI, SBP, DBP, y-glutamyltransferase activity, oral con-
traceptive use, smoking, physical excercise, and socioeconomic
status. A third model controlled for apo E phenotypes, in
addition to the variables controlled for in model 2. The average
Oj (i = 2,3,4) effects of the apo E alleles on the adjusted serum
lipid and (apo)lipoprotein concentrations and the variance a2 A
of these effects attributable to genotypic differences were
estimated according to the method of Sing and Davignon.5 This
a2 A is a component of the total genetic variance C^Q (5). Sig-
nificance of each estimated Oj (i = 2,3,4) was also tested.
A x2-goodness-of-Dt test was used to evaluate the genetic
Hardy-Weinberg equilibrium for the apo E polymorphism. Apo
E allele frequencies were estimated using the gene-counting
method. The difference in apo E allele frequencies between the
two regions was tested using a x2-assoriation test. Differences in
mean lipid and (apo)lipoprotein levels between apo E pheno-
typic groups were tested parametrically using one-way analysis
of variance with the Student-Newman-Keuls multiple range
test or Kruskal-Wallis non-parametric test. A significance level
of a = 0.05 was adopted throughout.
Results
Description of the studied population sample
Anthropometric and other characteristics of the Belgian
population sample, stratified by region, sex and 10-year age
classes, are presented in Table 1. Mean BMI was significantly
higher in French-speaking males than in Dutch-speaking males,
in both age classes. The BMI also tended to be higher in French-
speaking females than in Dutch-speaking females. Socio-
economic status and the age at graduation was generally lower
in Walloon participants compared to Flemish participants,
reaching statistical significance in nearly all strata.
Serum liplds and (apo)lipoprotein parameters
Average serum lipid, Lp(a) and apo A-I and B levels by region,
sex and age class are presented in Table 2. Cholesterol and LDL-
c levels were higher in Walloons, irrespective of gender and age
class. The difference was significant in 30-39 year old males.
Analogously, the apo B level was significantly higher in 30-39
year old male Walloons compared to their Flemish counterparts.
Other adverse characteristics of the lipid profile in Walloon
males were the significantly lower HDL-c and apo A-I levels in
30-39 year old participants.
Serum Lp(a) levels (Table 3) were similar in Walloons and
Flemings, median Lp(a) being 67 mg/1 in Flemings and 75 mg/1
in Walloons. The overall median Lp(a) level in the 900 Belgians
was 68 mg/1.
Factors influencing lipid, apolipoprotein and
Lp(a) parameters
Oral contraceptives
Oral contraceptives increased average serum triglyceride and
apo A-I levels in all strata (P < 0.05; data not shown). Ana-
logously, HDL-c levels showed a tendency to higher levels
in females on oral contraceptives. The Lp(a) levels were not
affected by oral contraceptive use, nor by smoking or physical
exercise.
Apo E polymorphism
The apo E phenotype distribution, as determined in a subgroup
(N = 249) that was matched for region, is presented in Table 4.
The observed phenotype distribution was in Hardy-Weinberg
equilibrium within each region. The apo E phenotype distribu-
tions were similar in Flemings and Walloons, consequently, the
data were pooled. The overall relative apo E allele frequencies
in the studied sample were 0.092 for e2, 0.767 for e3 and 0.141
for e4.
The average impact of the apo E polymorphism on apo
B-containing lipoprotein levels appeared large in this popula-
tion sample, cholesterol, LDL-c and apo B levels being lowest in
E2-carriers and highest in E4-carriers. The trend was obvious,
already by univariate analysis using unadjusted values (Table 5).
On the contrary, no significant effect of the apo E polymor-
phism could be demonstrated upon serum apo A-I, HDL-c,
triglyceride and Lp(a) levels.
Multivarlable models explaining phenotypic variance
The first and simplest MLR model (data not shown), controlling
for age, gender and BMI, explained 4-6.4% of the variances in
cholesterol, LDL-c and apo B levels, but 29.7% and 33.6% of
the apo A-I and HDL-c variances, respectively. Model 2, which
additionally adjusted for multiple lifestyle factors, explained
14.1-18.8% of the variances in cholesterol, LDL-c and apo B
levels, and 31.9, 33.9 and 39.9% of triglyceride, apo A-I and
HDL-c variances, respectively. The third MLR model controlling
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Table 1 Anthropometnc and other
Variable
Mean ± SD or %
MALE
Age (years)
Height (cm)
Weight (kg)
Body mass index (kg/m2)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
GGT" (U/l)
Age at graduation (years)
Current smokers (%)
Alcohol users (%)
Sodoeconomic class16 (%)
I
II
IIIN
niM
IV
V
FEMALE
Age (years)
Height (cm)
Weight (kg)
Body mass index (kg/m2)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
GGT3 (U/l)
Age at graduation (years)
Current smokers (%)
Alcohol users (%)
Oral contraceptive use (%)
Sodoeconomic class16 (%)
I
II
niN
UIM
rv
V
characteristics in Flemings
20-29 years
Flanders
N = 116
25.6 ±2.7
178.2 ± 6.0
72 3 ± 9.9
22.7 ±2.7
123 ± 11
76 ± 9
11.6 ± 6.3
21.3 ±2.3
23.3
89.7
13.9
45.3
28.7
11.3
0.9
-
N = 211
25.6 ± 2.6
166.1 ± 6.0
60.2 ± 9.4
21.8 ± 3.0
115 ± 10
73 ± 8
8.3 ± 4.2
20.5 ±2.1
23.2
64.0
67.3
5.2
42.2
35.5
10.4
6.2
0.5
and Walloons,
Wallonia
N = 41
26.2 ±2.4
176.9 ± 5.8
77.4 ± 12.3
24.7 ±3.6
126 ± 12
76 ± 9
16.2 ± 18.8
19.8 ±2.5
41 5
78.0
12.2
9.8
12.2
48.8
17.1
-
N = 32
25 7 ± 2.7
164.0 ± 5.5
60.9 ± 9.3
22.6 ± 3.1
119 ± 14
71 ± 8
8.9 ± 7.0
19.5 ± 1.9
28.1
50.0
65.6
-
28.1
25.0
31.3
15.6
-
as stratified by sex
P-value
0.227
0.246
0.008
0.002
0.101
0.811
0.433
0.001
0.043
0.107
<0.0005
0.891
0.055
0.692
0.143
0.163
0.333
0.791
0.014
0.701
0.186
1.000
0.002
and age category
30-39 years
Flanders
N= 164
34.7 ± 2.7
177.5 ± 6.6
75.7 ± 10.5
24.0 ± 3.0
123 ± 11
76±8
16.0 ± 12.9
21.3 ± 2.6
21.3
89.6
18.9
41.5
26.8
9.8
3.0
-
N= 196
34.6 ± 2.8
164.8 ± 5.6
60.2 ± 7.9
22.2 ± 2.7
116 ± 11
74 ± 8
8.8 ± 3.5
19.6 ± 2.8
27.0
63.8
39.3
4.1
36.7
31 1
7.7
16.3
4.1
Wallonia
N = 91
35.0 ±2.9
175.6 ± 6.1
79.3 ±12.0
25.7 ± 3.7
130 ± 13
79 ± 10
8.8 ± 3.5
19.6 ± 2.8
38.5
85.5
4.4
18.7
8.8
42.9
23.1
2.2
N = 53
34.8 ± 3.0
161.8 ± 7.5
61.1 ± 11.2
23.4 ±4.5
120 ± 15
74 ± 11
11.0 ± 6.9
18.8 ±2.6
37.7
58.5
50.9
-
28.3
20.8
20.8
20.8
9.4
/>-value
0.422
0.029
0.014
<0.0005
<0.0005
0.034
0.105
<0.0005
0.005
0.330
<0.0005
0.724
0.008
0.579
0.057
0.113
0.717
0.164
0.067
0.178
0.585
0.171
0.009
' Y-glutamyliransferase activity.
for apo E phenotypes in addition to the parameters controlled
for in model 2, is obviously the best, explaining 25-41% of the
observed phenotypic variation of all lipid parameters, except
for Lp(a). Common predictors of total cholesterol, LDL-c and
apo B levels were smoking, linear age, GGT (In) and apo E2-
containing phenotypes. None of the models predicted Lp(a)
variances (probability F statistics: NS).
Applying the second best MLR model to the entire Belgian
population sample (N = 900) smoking and BMI were major
predictors associated with all lipoprotein and apolipoprotein
levels, except with Lp(a) (data not shown). The activity of
y-glutamyltransferase, an indicator of alcohol (ab)use, was
positively associated with triglycerides, total and LDL-c, and
apo B levels. As expected, apo A-I and HDL-c were associated
positively with use of contraceptive hormones, and negatively
with smoking and BMI.
Average effects of the three common apo E alieles
on adjusted serum lipid and (apo)lipoprotein levels
Estimates and significances of the average effects of the com-
mon apo E alieles on adjusted serum lipid, apolipoprotein and
lipoprotein(a) levels are presented in Table 6. Striking are the
regional differences in apo E allelic effects on adjusted serum
lipid levels: in southerners the e4 and e2 effects upon adjusted
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Table 2 Mean (± SD) serum lipid, Upoprotein and apolipoprotein levels in Belgians, by region, sex and age category
Parameter
m e a n * SD
MALE
Triglycerides (mmol/1)
Cholesterol (mmol/1)
LDL-cholesterol (mmol/1)
(PVS)a
LDL-cholesterol (mmol/1)
(Friedewald)b
LDL-cholesterol (mmol/1)
(Friedewald, corrected for
Lp(a)-cholesterol)c
HDL-cholesterol (mmol/1)
Lp(a) (mg/1)
Ln Lp(a)d (Ln mg/1)
Apolipoprotein A-I (g/1)
Apolipoprotein B (g/1)
FEMALE
Triglycerides (mmol/1)
Cholesterol (mmol/1)
LDL-cholesterol (mmol/1)
(PVS)a
LDL-cholesterol (mmol/1)
(Friedewald)b
LDL-cholesterol (mmol/1)
(Friedewald, corrected for
Lp(a)-cholesterol)c
HDL-cholesterol (mmol/1)
Lp(a) (mg/1)
Ln Lp(a)d (Ln mg/1)
Apolipoprotein A-I (g/1)
Apolipoprotein B (g/1)
20-29 years
Flanders
N= 116
1.032 ±0.438
4.834 ± 0.767
3.126 ± 0.837
3.034 ± 0.737
2.937 ± 0.725
1.326 ±0.310
125 ± 169
4.082 ± 1.340
1.24 ± 0.21
0.70 ±0.16
N = 112
1.090 ± 0.404
5.111 ± 0.960
3.101 ± 1.015
2.963 ± 0.894
2.856 ± 0.885
1.653 ± 0.366
136 ± 177
4 188 ± 1.291
1.56 ±0.32
0.71 ±0.19
Wallonia
N = 41
1.213 ±0.711
5.087 ±0.815
3.248 ± 0.733
3.243 ± 0.639
3.097 ± 0.607
1.292 ± 0.282
188 ± 207
4.300 ± 1.672
1.21 ±0.20
0.72 ±0.16
N= 32
1.109 ±0.465
5.438 ± 1.100
3.424 ± 1.124
3.284 ± 1.016
3.136 ±0.964
1.649 ±0.392
192 ± 269
4.144 ± 1.708
1.52 ±0.29
0.73 ± 0.18
P-value
0 408
0.076
0410
0.108
0.207
0.539
-
0.406
0.495
0.523
0.725
0.080
0.099
0.064
0.101
0.961
-
0.888
0.537
0.726
30-39 years
Flanders
N = 164
1.381 ± 1.212
5.297 ± 0.892
3.533 ±0.898
3.400 ± 0.836
3.276 ± 0.800
1.284 ±0.290
165 ±204
4.312 ± 1.419
1.27 ±0.22
0.79 ±0.18
N= 196
1.005 ±0.464
5.045 ± 0.897
3.057 ± 0.946
2.954 ± 0.874
2.841 ± 0.862
1.634 ± 0.343
146 ± 166
4.283 ± 1.295
1.55 ±0.30
0.70 ± 0.18
WaUonia
N = 91
2.088 ±2.105
5.900 ± 1.455
3.936 ± 1.260
3.786 ± 1.247
3.651 ± 1.241
1.164 ±0.290
174 ± 221
4.354 ± 1.402
1.16 ±0.21
0.87 ± 0.25
N = 53
1.148 ± 0.579
5.212 ± 1.160
3.179 ± 1.188
3.107 ± 1.100
3.001 ± 1.050
1.583 ±0.357
137 ± 183
4.013 ± 1.524
1.50 ±0.31
0.70 ± 0.23
P-value
0.002
<0.001
0.009
0.009
0.010
0.002
-
0.822
<0.001
0.010
0.136
0.333
0.490
0.352
0.253
0.340
-
0.197
0.221
0.926
a
 Low density Upoprotein (LDL)-cholesterol as determined after polyvinyl sulfate (PVS) precipitation of LDL and Lp(a), by subtracting supernatant cholesterol
from total cholesterol.
b
 LDL-cholesterol as estimated by the Friedewald formula, I.e. LDL-cholesterol (mmol/1) = total cholesterol - high density cholesterol (HDL)-cholesterol -
triglycerides/2.2.
c
 LDL-cholesterol as estimated by the Friedewald formula, corrected for Lp(a)-cholesteroL I e. LDL-cholesterol (mmol/1) = total cholesterol - HDL-cholesterol
- triglycerides/2.2 - (0.3"Lp(a)/386 7) 6
d
 Ln Lp(a) = naturally logarithmically transformed Lp(a).
apo B and LDL-c levels were approximately +12% and -15%
respectively (P < 0.05), whereas they were halved (»-i-5%; NS)
and doubled (=»-25%; P < 0.05) respectively in northerners.
Overall, presence of the e2 allele reduced serum cholesterol
levels on average by 11 %, and LDL-c and apo B levels by 20 and
19%, respectively (P < 0.05). Presence of the e4 allele increased
cholesterol levels by 5% (NS), and LDL-c and apo B levels by
11% (P < 0.05). In case of the e3 allele serum triglyceride levels
were significantly lower (P < 0.05).
Contribution of the apo E locus to the total
variability of serum lipids and (apo)Iipoproteins
in the Belgian population sample
Using the third MLR model, the apo E locus explained 8.8% of
the total cholesterol variance, 13.5% of the LDL-c variance and
16.9% of the apo B variance. Less than 4% of the HDL-c, apo
A-I, triglyceride and Lp(a) variances could be attributed to the
apo E locus (data not shown).
Discussion
It has been established that besides lifestyle factors, heridity
contributes to about 50% of interindividual serum cholesterol
variation.22 The involvement of many candidate genes in deter-
mining phenotypic variation in serum cholesterol and other
serum lipids is supported by research reviewed by e.g. Ferrell.22
In general, polymorphic variation in several genes influences
variation in a particular trait, e.g. serum cholesterol, and each
gene influences variation in more than one trait. As a rule, a par-
ticular gene explains only a fraction of variation in a particular
trait. The apo E polymorphism e.g. explains 1 % of the variation
in total serum cholesterol in males, but 10% in females.23 The
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Table 3 Serum lipoprotein (Lp(a)) levels in 900 randomly recruited Belgian employees, by region, sex and age class
Region
Flanders
Wallonia
Overall
Age category
(years)
20-29
30-39
Pooled
20-29
30-39
Pooled
Sex
Male
Female
Male
Female
Male
Female
Male
Female
No. of
subjects
115
210
162
196
683
41
32
91
53
217
900
Lp(a)
mean (mg/1)
125
136
165
146
144
188
192
174
137
170
150
Lp(a)
5th
6
8
8
8
8
3
4
5
4
4
6
percentlles (mg/1)
10th
10
11
11
13
12
4
4
13
6
8
11
25th
31
30
26
27
30
24
15
34
21
26
28
50th
64
63
77
72
67
81
70
69
61
75
68
75th
131
171
243
213
186
351
251
240
141
247
192
90th
355
366
475
437
403
508
689
496
415
513
426
95th
497
530
549
539
536
634
834
698
571
664
561
After natural log transformation, average Lp(a) was not significantly different between Walloons and Flemings (P = 0.983).
Table 4 Apolipoprotein (apo) E phenotype distribution in 249
apparently healthy Belgians, stratified by region
Apo E phenotype
E2/2
E2/3
E3/3
E4/2
E4/3
E4/4
All phenotypes
Flanders"
1
18
77
1
27
1
125
Wallonia"
0
21
69
4
24
6
124
Pooled
1
39
146
5
51
7
249
a
 The apo E phenotype distnbuuon is similar in Flemings and Walloons
(X2 = 7 213; d.f = 5; P = 0.2053).
gene coding for the apo(a) molecule is an exception, allelic
variation in the apo(a) gene determining as much as 90% of
the interindividual variation in Lp(a) mass, and hence Lp(a)-
cholesterol, in the population at large.24
Although, with respect to the Belgian regional cholesterol
differences, intake of a diet rich in saturated fat has been fre-
quently invoked to explain the more adverse serum lipid distri-
bution and higher mortality rate due to cardiovascular disease
in Wallonia than in Flanders,3'4 we aimed to examine whether
differences in genetic stock between Belgian northerners and
southerners might exist and contribute to the observed regional
cholesterol differences. Hitherto, serum Lp(a) levels and apo E
polymorphism, two genetically determined cardiovascular risk
factors that affect serum cholesterol, were assessed.
The study was designed using an apparently healthy working
population from the northern (Flanders) and the southern
(Wallonia) region of Belgium. The study population has several
advantages. First, the population is homogeneous with regard
to ethnic origin as all participants were Caucasians. Second, the
population is considered to be representative for the northern
and southern regions of Belgium respectively because no special
exclusion criteria were used—with the exception of the exclu-
sion of non-Caucasians, and pregnant or hysterectomized
women—and because participants were recruited from 32 work-
sites located in the northern pan of Belgium, and 15 worksites
in the southern part of Belgium. Third, the study population
contains both males and females at a reproductive age (20-39
years), excluding effects of menopause on serum lipid profiles.
Fourth, information was collected on various factors that relate
to lifestyle, such as smoking, physical exercise, oral contraceptive
use, alcohol use and GGT activity, or that reflect both en-
vironmental and genetic factors, such as BMI. Fifth, fasting sera
were collected, enabling vaJid determinations of HDL-c, LDL-c
and triglycerides.18'19-25
Major outcomes of this study were the following. First, the
more adverse serum lipid profile In southerners compared to
northerners (Table 2) was reconfirmed in this study, the dif-
ference being significant in 30-39 year old males. This finding is
in accordance with previous publications examining north-
south differences in cardiovascular risk factor distribution, and
implies that regional differences in serum lipid distribution in
Belgium, first observed in the 1960s, still persist in the 1990s.1 "*
Second, similar median and log mean Lp(a) levels were found
in Belgian northerners and southerners (Table 3). Accordingly,
mean estimated LDL-c levels remained 5-11% lower in Flemings
compared to Walloons within each age and gender dass, also
after correcting for Lp(a)-cholesterol content (Table 2). After
all, the average contribution of Lp(a)-cholesterol to estimated
LDL-c was similar in both regions and amounted maximally
4.5% within each category. Consequently Lp(a), and hence
Lp(a)-cholesterol, do not contribute to the observed regional
cholesterol differences.
Third, the apo E phenotype distribution was found to be
similar in both regions (Table 4). Besides, the overall apo E allele
frequencies counted in this study were similar to the apo E
allele frequencies reported by Braeckman et al. in 30-59 year
old Flemish males (l^, f^  and f,,4: 0.092, 0.767 and 0.141 (this
study) versus 0.072, 0.765 and 0.16326). Also, the associations
of apo E polymorphism with the lipids and apolipoproteins ana-
lysed (Tables 5 and 6) were consistent with the well identified
effects of apo E, the average effect of the e2 allele being to lower
LDL-c and apo B, and of the e4 allele being to increase LDL-c
and apo B . 5 ' 6 - 9 - 2 3 Whereas the e effect on serum LDL-c and
apo B levels is consistent across most population studies, there
are controversial results about the e effect on triglycerides, since
these vary widely within and among individuals, masking a
dear effect of apo E phenotype. In this study e2 and e4 alleles
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Table 5 Unadjusted serum Upid, apolipoproteln and Hpoprotein (Lp(a)) levels by apolipoprotein (apo) E phenolype in 249 apparently healthy
Belgian males and females
Mean ± SD
No.
Relative frequency* (%)
Variable
Triglycerides (mmol/1)
Cholesterol (mmol/1)
LDL-cholesterol (mmol/1)
(PVS)d
HDL-cholesterol (mmol/1)
Apolipoprotein A-I (g/1)
Apolipoprotein B (g/1)
Ln Lp(a)e (Ln mg/1)
Median Ln Lp(a) (Ln mg/1)
ApoE
E2/2
1
0.4
1.184
3.501
1.821
1.19
1.15
0.32
4.852
-
phenotype
E2/3
39
15.7
1.552 ± 1.226
4.878 ± 1.001
2.867 ± 0.885
1.382 ±0.397
1.27 ± 0.26
0.67 ± 0.22
3.965 ± 1.602
3.714
1.191 ±
5.454 ±
3.573 ±
1.431 ±
1.27
0.80
4.397 ±
E3/3
146
58.6
0.829
1.063
1.100
0.372
± 0.24
±0.21
1.419
4.477
1
5
3
1
5
E4/2
5
2.0
.431 ±0.408
.767 ± 1.061
.713 ± 1.105
.360 ± 0.499
1.24 ±0.23
0.86 ±0.17
.109± 1.161
5.124
1.499 ±
5.633 ±
3 816±
1.370 ±
1.24
0.86
4.215 ±
E4/3
51
20.5
1.888
1.198
1.143
0.426
±0.23
± 0.24
1.646
4.331
2
6
4
1
3
.993 ±
.709 ±
.310 ±
.304 ±
1.25
0.97
.565 ±
E4/4
7
2.8
4.317
1.981
1.571
0.503
±0.45
±0.30
0.558
3.526
One-way ANOVA
"(SNK - KW)b
Probability F ratio
-
-
NSC
0.0011
0.0001
NS
NS
<0.0001
NS
-
• The phenotype distribution is in Hardy-Weinberg equilibrium (Goodness-of-fit test; X2 = 2 334; d.f. = 5; P = 0.801).
P-value Indicating the significance level of the difference among phenotypic means of the lipid traits, calculated by one-way ANOVA and using a Student-
Newman-Keuls (SNK) parametric test or a Kruskal-Wallis (KW) non-parametric test.
c
 NS: not significant at a = 0.05.
d
 Low density lipoprotein (LDL)-cholesteroI as determined after polyvinyl sulfate (PVS) precipitation of LDL and Lp(a), by subtracting supernatant cholesterol
from total cholesterol.
c
 Ln Lp(a): naturally logarithmically transformed Lp(a).
Table 6 Estimates and significandes of the average effect of the three common apo E alleles on adjusted serum lipid, apolipoprotein and
llpoprotein(a) levels in a random sample of unrelated, healthy Flemings and Walloons (N = 249)
Estimated average effect of the apo E alleles
Parameter
Cholesterol (mmol/1)
LDL-cholesterol (PVS)a (mmol/1)
Apolipoprotein B (g/1)
Triglycerides (mmol/1)
Lp(a) (mg/1)
HDL-cholesterol (mmol/1)
Apolipoprotein A-I (g/1)
Serum lipld, apolipoprotein and Lp(a) data were adjusted lor age, sex, body mass index, systolic and diastolic blood pressure, smoking, physical exercise, use
of oral contraceptives, y-glutamyltransferase activity and sodoeconomic status. Apo E allelic effects were calculated according to the method of Sing and
Davignon.'
" Low density lipoprotein (LDL)-cholesterol as determined after polyvinyl sulfate (PVS) precipitation of LDL and Lp(a), by subtracting supernatant cholesterol
from total cholesterol.
* Apo E allelic effects significant at a = 0.05
Flanders
a2
x 0.85*
x 0.73*
x 0.77*
x 1.12
X0.75
-0.046
+0.026
« 3
X 1.02
x 1.03*
X 1.02
X0.98
x 1.01
+0.001
-0.004
a4
x 1.02
x 1.04
x 1.06
x 1.05
x 1.13
+0.023
+0.002
Wallonia
a 2
x 0.92*
x 0.85*
X0.85*
x 1.07
x 1.05
+0.003
+0.006
a 3
x 1.00
x 1.00
x 1.00
xO.97
x 1.07
+0.016
+0.007
a 4
X 1.06
x 1.12*
x 1.13*
x 1.12
X0.68
-0.091
-0.040
Pooled
« 2
x 0.89*
X0.80
X0.81*
x 1.14
xO.96
-0.036
+0.010
« 3
x 1.00
x 1.01
x 1.01
x 0.97*
x 1.03
+0.014
+0.004
a 4
X 1.05
x 1.11*
x l . l l *
x 1 1 1
x 0.86
-O.051
-0.027
tended to increase the level of triglycerides (NS), in accordance
with the meta-analysis of Dallongeville et al.,21 and the EARS
study results.9
Strikingly, the magnitudes of the apo E allelic effects upon
adjusted LDL-c and apo B levels differed between Belgian
northerners and southerners (Table 6). In northerners, the LDL-
c and apo B increasing effect attributable to e4 was minor and
insignificant (-+5%), whereas the decreasing effect by e2 was
huge and significant (--25%); in southerners however, e4
increased adjusted LDL-c and apo B levels by «+12% (P < 0.05),
while £2 decreased these lipid parameters to a similar extent
(P < 0.05). The less favourable apo E allelic effects in south-
erners compared to northerners cause the more adverse lipid
profile in southerners. Although the association of £2 with lower
LDL-c and apo B, and of e4 with higher LDL-c and apo B is well
established in the general population, considerable heterogeneity
with respect to the magnitude of the allelic effects estimated in
different populations has been reported.6 Several studies have
shown a lowering effect of e2 on cholesterol levels, double to
fourfold the e4 increasing effect (Flemings), whereas similar
effects of both have been reported elsewhere (Walloons28-29).
Eco-genetic interactions have been held responsible, at least in
homogeneous population samples,30 whereas confounding might
have occurred in case of heterogeneous samples due to different
apo E allele frequencies.2 As to the origin of the regional differ-
ences in e effects between Belgian northerners and southerners,
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a gene-environment interaction could cause different allelic
effects under different environmental conditions in the same
population. In view of the well-documented higher intake of
saturated fat and dietary cholesterol in the south of Belgium
compared to the north,3 '4 we hypothesize that the less favour-
able saturated fat intake in southerners explains the differences
in e effects. Suppon is given by a recent meta-analysis, showing
that apo E genotype effects are modulated via alterations of
amount and type of dietary fat,30 and by others.31 In contrast
to dietary saturated fat, the apo E gene loci do not have a major
effect on the response of lipid levels to increased dietary
cholesterol.32
Overall, the apo E locus contributed substantially to the vari-
ances of serum total cholesterol, LDL-c and apo B (8.8, 13.5 and
16.9% respectively), far exceeding the 0.9% and 2.8% reported
for total cholesterol respectively apo B by Braeckman et al. in
Flemish males.26 In view of the reported differences between
men and women with regard to the impact of the apo E geno-
type on both the means and variances of the distributions of
serum lipids and apolipoproteins,36 the large contribution of the
apo E locus to the variances of cholesterol, LDL-c and apo B is
probably related to the inclusion of women in the sample, and
especially of women taking exogenous hormones (57% of the
studied females). Alter all, the apo E polymorphism is reported
to explain up to 10% of the adjusted interindividual serum chol-
esterol variation in females, compared to only 1% in males.23
Furthermore, if women are included the increasing effect of e4
is smaller and the decreasing effect of e2 is larger, as one can
expect from the protective effect of oestrogen through upregu-
lation of the hepatic LDL receptor.33 Also, women having an
e4 allele and taking exogenous hormones showed a greater
cholesterol-elevating effect of this allele than women not taking
hormones.36 In accordance with others5 '6 '23 '27 the contribu-
tion of the apo E locus to the triglyceride, apo A-I and HDL-c
variances was minor (3.5, 1.0 and 2.0% respectively).
Fourth, the apo E polymorphism did not affect serum Lp(a)
levels, supporting the contention that the LDL-receptor is not a
major contributor to the Lp(a) catabolism.12'24 The lack of rela-
tionship between apo E phenotype and Lp(a) was also observed
by Schaefer et al. in the Framingham Offspring Study33 and
Muros et al. in a Spanish working population of Tenerife,34 but
is dissimilar to the findings of Tiret et al. in the EARS study,9
where e2 had a lowering effect on Lp(a), and to the findings of
de Knijff et al.?* who showed in a Dutch population sample a
25% increasing effect on serum Lp(a) level by the £4 allele, equal
and opposite to the e2 effect.
To the best of our knowledge, this study is the first examining
the contribution of Lp(a) and apo E polymorphism to regional
cholesterol differences in Flanders and Wallonia. Drawbacks of
this study may be related to the limited sample size and the faa
that apo E polymorphism was checked in a subgroup only.
Second, no dietary survey was performed, and hence the
hypothesis regarding a diet-apo E genotype interaction being
responsible for the regional differences in e effects, remains to
be proven. Third, other candidate gene loci which have not
been investigated here might also be involved and co-determine
responsiveness of serum lipids to dietary fat alterations.
In conclusion, the more adverse lipid profile in Belgian south-
erners compared to northerners is reconfirmed in this study. As
to the origin of the regional cholesterol differences, no differences
could be demonstrated in serum Lp(a) or apo E phenotype
distribution between northerners and southerners, supporting a
similar genetic background. On the contrary, the average effects
of the apo E alleles upon adjusted LDL-c and apo B levels dif-
fered between the regions, the adverse e4 effect being doubled
and the protective e2 effect being halved in southerners com-
pared to northerners. These findings suggest that similar genetic
information variably affects intermediate traits in Flanders and
Wallonia in particular environments.
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